|
601 |
Profit of Ajanta Pharma up 92% |
Download (69.29 KB)  |
28/01/2014 |
|
602 |
Winner takes all |
Download (157.49 KB) |
28/01/2014 |
|
603 |
Ajanta Pharma Q3 net rises 92% at Rs. 62 Crore |
Download (51.85 KB) |
28/01/2014 |
|
604 |
Wyeth Q3 profit dips 32% to Rs 17.46 crore |
Download (54.53 KB) |
28/01/2014 |
|
605 |
Cadila Healthcare exits Japan business |
Download (58.8 KB) |
28/01/2014 |
|
606 |
US regulator shadow on Ranbaxy stock lengthens |
Download (187.95 KB) |
27/01/2014 |
|
607 |
Sniffing an opportunity |
Download (200.66 KB) |
27/01/2014 |
|
608 |
Our vision become a powerhouse for diabetes cure |
Download (176.42 KB) |
27/01/2014 |
|
609 |
Biocon to take breast cancer drug to emerging markets |
Download (113.75 KB) |
27/01/2014 |
|
610 |
Flies found in store-room of Ranbaxy plant at Tonsa Plants |
Download (78.98 KB) |
27/01/2014 |
|
611 |
Investing lesson from Ranbaxy share slump Diversification is key |
Download (114.69 KB) |
27/01/2014 |
|
612 |
Recovery of Ranbaxy difficult Analyst |
Download (154.28 KB) |
26/01/2014 |
|
613 |
USA bans all drugs from Ranbaxy |
Download (102.11 KB) |
25/01/2014 |
|
614 |
Glenmark Pharma Q3 adjusted net profit up 32% |
Download (106.67 KB) |
25/01/2014 |
|
615 |
Shasun Pharma to buy out partner stake in joint venture |
Download (103.53 KB) |
25/01/2014 |
|
616 |
Contribution from Malaysia facility can only come in FY16 |
Download (160.79 KB) |
24/01/2014 |
|
617 |
Nod for aurobindo diabetes drug |
Download (65.51 KB) |
24/01/2014 |
|
618 |
Novartis India net down 47% at Rs. 15.23 crore |
Download (74.36 KB) |
24/01/2014 |
|
619 |
Unichem drug gets FDA nod |
Download (45.54 KB) |
24/01/2014 |
|
620 |
R&D boost Biocon net profit up 14% |
Download (67.07 KB) |
24/01/2014 |
औषध विभाग
Department of
